Skip Nav Destination
Issues
15 December 2017
-
Cover Image
Cover Image
The cover shows a section of a HBCx-22 AR/ER+ breast cancer patient-derived xenograft. Immunohistochemical staining shows AR expression in both the cytoplasm and the nuclei. For details, see the article by Yu and colleagues on page 7608 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Statistics in CCR
CCR Drug Updates
FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen
Amy Barone; Dow-Chung Chi; Marc R. Theoret; Huanyu Chen; Kun He; Dubravka Kufrin; Whitney S. Helms; Sriram Subramaniam; Hong Zhao; Anuja Patel; Kirsten B. Goldberg; Patricia Keegan; Richard Pazdur
Cancer Therapy: Clinical
Author Choice
A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non–small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations
Helena A. Yu; Alexander Spira; Leora Horn; Jared Weiss; Howard West; Giuseppe Giaccone; Tracey Evans; Ronan J. Kelly; Bhardwaj Desai; Andrew Krivoshik; Diarmuid Moran; Srinivasu Poondru; Fei Jie; Kouji Aoyama; Anne Keating; Geoffrey R. Oxnard
Immune Activation in Early-Stage Non–Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab
John S. Yi; Neal Ready; Patrick Healy; Chelsae Dumbauld; Robyn Osborne; Mark Berry; Debra Shoemaker; Jeffrey Clarke; Jeffrey Crawford; Betty Tong; David Harpole; Thomas A. D'Amico; Frances McSherry; Frank Dunphy; Shannon J. McCall; Jared D. Christensen; Xiaofei Wang; Kent J. Weinhold
A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma
Marjorie G. Zauderer; Anne S. Tsao; Tao Dao; Katherine Panageas; W. Victoria Lai; Andreas Rimner; Valerie W. Rusch; Prasad S. Adusumilli; Michelle S. Ginsberg; Daniel Gomez; David Rice; Reza Mehran; David A. Scheinberg; Lee M. Krug
A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid Tumors
Antonio Jimeno; Michael Gordon; Rashmi Chugh; Wells Messersmith; David Mendelson; Jakob Dupont; Robert Stagg; Ann M. Kapoun; Lu Xu; Shailaja Uttamsingh; Rainer K. Brachmann; David C. Smith
Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab
Jakub Krejcik; Kris A. Frerichs; Inger S. Nijhof; Berris van Kessel; Jeroen F. van Velzen; Andries C. Bloem; Marloes E.C. Broekmans; Sonja Zweegman; Johan van Meerloo; René J.P. Musters; Pino J. Poddighe; Richard W.J. Groen; Christopher Chiu; Torben Plesner; Henk M. Lokhorst; A. Kate Sasser; Tuna Mutis; Niels W.C.J. van de Donk
Personalized Medicine and Imaging
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts
Arian Lundberg; Linda S. Lindström; J. Chuck Harrell; Claudette Falato; Joseph W. Carlson; Paul K. Wright; Theodoros Foukakis; Charles M. Perou; Kamila Czene; Jonas Bergh; Nicholas P. Tobin
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
Eric Y. Zhao; Yaoqing Shen; Erin Pleasance; Katayoon Kasaian; Sreeja Leelakumari; Martin Jones; Pinaki Bose; Carolyn Ch'ng; Caralyn Reisle; Peter Eirew; Richard Corbett; Karen L. Mungall; Nina Thiessen; Yussanne Ma; Jacqueline E. Schein; Andrew J. Mungall; Yongjun Zhao; Richard A. Moore; Wendie Den Brok; Sheridan Wilson; Diego Villa; Tamara Shenkier; Caroline Lohrisch; Stephen Chia; Stephen Yip; Karen Gelmon; Howard Lim; Daniel Renouf; Sophie Sun; Kasmintan A. Schrader; Sean Young; Ian Bosdet; Aly Karsan; Janessa Laskin; Marco A. Marra; Steven J.M. Jones
Author Choice
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy
Elizabeth Smyth; Shenli Zhang; David Cunningham; Andrew Wotherspoon; Richie Soong; Clare Peckitt; Nicola Valeri; Matteo Fassan; Massimo Rugge; Alicia Okines; William Allum; Sally Stenning; Matthew Nankivell; Ruth Langley; Patrick Tan
Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium
Pawadee Lohavanichbutr; Lori C. Sakoda; Christopher I. Amos; Susanne M. Arnold; David C. Christiani; Michael P.A. Davies; John K. Field; Eric B. Haura; Rayjean J. Hung; Takashi Kohno; Maria Teresa Landi; Geoffrey Liu; Yi Liu; Michael W. Marcus; Grainne M. O'Kane; Matthew B. Schabath; Kouya Shiraishi; Stacey A. Slone; Adonina Tardón; Ping Yang; Kazushi Yoshida; Ruyang Zhang; Xuchen Zong; Gary E. Goodman; Noel S. Weiss; Chu Chen
Cancer Therapy: Preclinical
Author Choice
Modulation of Navitoclax Sensitivity by Dihydroartemisinin-Mediated MCL-1 Repression in BCR-ABL+ B-Lineage Acute Lymphoblastic Leukemia
Amit Budhraja; Meghan E. Turnis; Michelle L. Churchman; Anisha Kothari; Xue Yang; Haiyan Xu; Ewa Kaminska; John C. Panetta; David Finkelstein; Charles G. Mullighan; Joseph T. Opferman
CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors
Irene M. Min; Enda Shevlin; Yogindra Vedvyas; Marjan Zaman; Brian Wyrwas; Theresa Scognamiglio; Maureen D. Moore; Weibin Wang; Susan Park; Spencer Park; Suraj Panjwani; Katherine D. Gray; Andrew B. Tassler; Rasa Zarnegar; Thomas J. Fahey, III; Moonsoo M. Jin
Author Choice
Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null Tumors
James T. Lynch; Urszula M. Polanska; Oona Delpuech; Urs Hancox; Antonio G. Trinidad; Filippos Michopoulos; Carol Lenaghan; Robert McEwen; James Bradford; Radek Polanski; Rebecca Ellston; Alvaro Avivar-Valderas; James Pilling; Anna Staniszewska; Marie Cumberbatch; Susan E. Critchlow; Francisco Cruzalegui; Simon T. Barry
Mutational Analysis of Gene Fusions Predicts Novel MHC Class I–Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer
Jennifer L. Kalina; David S. Neilson; Yen-Yi Lin; Phineas T. Hamilton; Alexandra P. Comber; Emma M.H. Loy; S. Cenk Sahinalp; Colin C. Collins; Faraz Hach; Julian J. Lum
Biology of Human Tumors
Author Choice
A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer
Caroline Kreuzinger; Angelika Geroldinger; Dominiek Smeets; Elena Ioana Braicu; Jalid Sehouli; Julia Koller; Andrea Wolf; Silvia Darb-Esfahani; Korinna Joehrens; Ignace Vergote; Adriaan Vanderstichele; Bram Boeckx; Diether Lambrechts; Hani Gabra; G. Bea A. Wisman; Fabian Trillsch; Georg Heinze; Reinhard Horvat; Stephan Polterauer; Els Berns; Charles Theillet; Dan Cacsire Castillo-Tong
The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma
Susanna L. Cooke; Darren Ennis; Lisa Evers; Suzanne Dowson; Mei Yen Chan; James Paul; Lynn Hirschowitz; Rosalind M. Glasspool; Naveena Singh; Sarah Bell; Elizabeth Day; Agata Kochman; Nafisa Wilkinson; Philip Beer; Sancha Martin; David Millan; Andrew V. Biankin; Iain A. McNeish; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership; On Behalf of the Scottish Genomes Partnership
Author Choice
Head and Neck Squamous Cell Carcinomas Are Characterized by a Stable Immune Signature Within the Primary Tumor Over Time and Space
Oliver Wood; James Clarke; Jeongmin Woo; Adal H. Mirza; Christopher H. Woelk; Gareth J. Thomas; Pandurangan Vijayanand; Emma King; Christian H. Ottensmeier
Acknowledgment to Reviewers
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds